EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Multicenter, Randomized, Single-Blind Trial Evaluating a Multi-Porous Urethral Catheter with Continuous Local Ropivacaine Infusion for the Reduction of Postoperative Catheter-Related Bladder Discomfort

Sangmin Lee iD, Kwang Taek Kim, Tae Beom Kim, Kyung Jin Chung, Kookjin Huh, Hwanik Kim iD, Sang Hoon Song iD

Journal of Clinical Medicine · 13.06.2025 · 14 (12) · 4215

DOI: 10.3390/jcm14124215 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 13.06.2025. Verfasst von Sangmin Lee und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Health Industry Development Institute, Songmin Medicare, Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Catheter-related bladder discomfort (CRBD) commonly occurs in patients undergoing urologic surgery and significantly affects patient comfort and recovery. We evaluated the efficacy and safety of continuous local ropivacaine infusion using a specialized multi-porous urethral catheter in reducing postoperative CRBD.

Methods

This multicenter, prospective, randomized, single-blind trial enrolled 136 male patients undergoing short-term catheterization after urologic surgery. Participants were randomized into three groups—a control group receiving saline infusion, Group 1 receiving 0.5% ropivacaine at 1 mL/h, and Group 2 receiving 0.5% ropivacaine at 2 mL/h—for up to 48 h via a multi-porous urethral catheter. The primary outcome was the incidence of CRBD at 24 h postoperatively. Secondary outcomes included changes in urethral pain assessed by a visual analog scale (VAS), urinary symptom scores, complication rates, and patient-reported catheter inconvenience and reuse intention using Likert scales.

Results

The incidence of CRBD was significantly lower in Group 1 (19.6%) and Group 2 (11.1%) compared to the control group (44.4%; p = 0.001), demonstrating a clear dose–response relationship. Changes in urethral pain scores (VAS) from baseline were significantly lower in the ropivacaine groups compared to the control (p = 0.023). Complication rates were similar among groups (control 13.3%, Group 1 6.5%, Group 2 15.6%; p = 0.378), although catheter leakage occurred more frequently in Group 2, without statistical significance (p = 0.122).

Conclusions

Continuous local ropivacaine infusion using a multi-porous urethral catheter effectively reduces the incidence of postoperative CRBD without increasing side effects. This approach may improve patient comfort during perioperative catheter management.

Schlagwörter

Stichwörter der Autor:innen

anestheticslocalpainpostoperativerandomized controlled trialropivacaineurinary catheterizationurologic surgical procedures

Autor:innen und Institutionen

  • Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea.
  • Department of Urology, Gachon University Gil Medical Center, Gachon University School of Medicine, Incheon 21565, Republic of Korea.
  • Department of Urology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Republic of Korea.

ORCID-Profile: Sangmin Lee, Hwanik Kim, Sang Hoon Song

Förderung

  • Korea Health Industry Development Institute
  • Songmin Medicare
  • Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)
  • Ministry of Health and Welfare, Republic of Korea

Zitieren

APA

Lee, S., Kim, K. T., Kim, T. B., Chung, K. J., Huh, K., Kim, H., & Song, S. H. (2025). A Multicenter, Randomized, Single-Blind Trial Evaluating a Multi-Porous Urethral Catheter with Continuous Local Ropivacaine Infusion for the Reduction of Postoperative Catheter-Related Bladder Discomfort. Journal of Clinical Medicine, 14(12), 4215. https://doi.org/10.3390/jcm14124215

Vancouver

Lee S, Kim KT, Kim TB, Chung KJ, Huh K, Kim H, et al. A Multicenter, Randomized, Single-Blind Trial Evaluating a Multi-Porous Urethral Catheter with Continuous Local Ropivacaine Infusion for the Reduction of Postoperative Catheter-Related Bladder Discomfort. Journal of Clinical Medicine. 2025;14(12):4215. doi:10.3390/jcm14124215

BibTeX
@article{Lee2025,
  author = {Lee, Sangmin and Kim, Kwang Taek and Kim, Tae Beom and Chung, Kyung Jin and Huh, Kookjin and Kim, Hwanik and Song, Sang Hoon},
  title = {A Multicenter, Randomized, Single-Blind Trial Evaluating a Multi-Porous Urethral Catheter with Continuous Local Ropivacaine Infusion for the Reduction of Postoperative Catheter-Related Bladder Discomfort},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {4215},
  doi = {10.3390/jcm14124215}
}
Kostenlos starten →